Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report has been added to ResearchAndMarkets.com’s offering. The Global…
AFFiRiS AG, a clinical-stage biopharmaceutical company developing novel disease-modifying specific active immunotherapies (SAITs) for patients with neurodegenerative diseases, will proceed with the preparations for the planned phase 2 study and confirms its intended initiation in the US and Europe in the second half of 2020.
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results…
Trial met primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated…
– Application is being reviewed under FDA’s Real-Time Oncology Review pilot program – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member…
TAIZHOU, China–(BUSINESS WIRE)–China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the…
LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Epizyme to be the exclusive specialty pharmacy…
DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (3rd Edition)” report has been added to ResearchAndMarkets.com’s offering. This report…
Global awards program celebrates emerging leadership in pharma and biotech CRANBURY, N.J.–(BUSINESS WIRE)–#biotech—Pharmaceutical Executive®, a multimedia platform for industry leaders…
MARIETTA, Ohio–(BUSINESS WIRE)–#AAGP–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) announces that the Company has taken procession of an additional…